Literature DB >> 426503

Pharmacokinetics of amoxicillin: Dosage nomogram for patients with impaired renal function.

G Humbert, D A Spyker, J P Fillastre, A Leroy.   

Abstract

Amoxicillin pharmacokinetics after intravenous administration were studied in patients with normal renal function, with impaired renal function, and during hemodialysis. The average urinary recovery was 68% in patients with normal renal function. Serum half-life was highly correlated (r = 0.967) with creatinine clearance corrected for body weight. Expected half-life was 71 min for a corrected creatinine clearance of 100 ml/min per 70 kg and 16 h in the anephric patient. Average amoxicillin half-life on hemodialysis was 3.6 h. We present a dosage nomogram for making appropriate adjustments to loading dose based on patient weight and maintenance dose based on corrected creatinine clearance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 426503      PMCID: PMC352595          DOI: 10.1128/AAC.15.1.28

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  [Practical modifications concerning the determination of antibiotics in clinical practice].

Authors:  Y CHABBERT; H BOULINGRE
Journal:  Rev Fr Etud Clin Biol       Date:  1957-06

2.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

3.  Amoxycillin: pharmacokinetic studies in normal subjects, patients with pernicious anaemia and those with renal failure.

Authors:  D H Lawson; A K Henderson; R R McGeachy
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

4.  Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects.

Authors:  W J Jusko; G P Lewis; G W Schmitt
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

5.  Pharmacokinetics of amoxicillin.

Authors:  D Zarowny; R Ogilvie; D Tamblyn; C MacLeod; J Ruedy
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

6.  Multiple dose kinetics and drug dosage in patients with kidney disease.

Authors:  L Dettli; P Spring; S Ryter
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

7.  Comparative effects of amoxycillin and ampicillin in the treatment of experimental mouse infections.

Authors:  K R Comber; C D Osborne; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

8.  Gentamicin dosage.

Authors: 
Journal:  Ann Intern Med       Date:  1977-03       Impact factor: 25.391

9.  "Comparably massive" penicillin G therapy in renal failure.

Authors:  C S Bryan; W J Stone
Journal:  Ann Intern Med       Date:  1975-02       Impact factor: 25.391

10.  Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.

Authors:  D A Spyker; R J Rugloski; R L Vann; W M O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

View more
  5 in total

1.  A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma.

Authors:  J T Slattery
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

Review 2.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

3.  Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients.

Authors:  Won-Chul Chang; Young-Il Jo; Hyung-Seok Park; Joon Jegal; Jung-Hwan Park; Jong-Ho Lee; Choon-Jo Jin
Journal:  Clin Exp Nephrol       Date:  2010-07-15       Impact factor: 2.801

Review 4.  Amoxycillin injectable: a review of its antibacterial spectrum, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-09       Impact factor: 9.546

5.  Applications of minimal physiologically-based pharmacokinetic models.

Authors:  Yanguang Cao; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-11-23       Impact factor: 2.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.